How much does a bottle of the targeted drug Sotoracib cost?

Sotorasib is a drug that targets the KRAS G12C mutation and is used to treat patients with certain types of non-small cell lung cancer. This type of mutation has previously been considered an "undruggable" target, so the emergence of sotorasib is an important milestone. At present, the drug has not been officially launched in mainland China. Domestic patients cannot purchase it directly through hospitals or pharmacies and can only obtain the drug through overseas channels.

In overseas markets, the price of the original drug of sotorasibu is relatively high, and it is mainly divided into two types: the European version and the Hong Kong version. Due to high R&D costs, strict approvals, and additional costs such as transportation and agency, the price of these original drugs is generally tens of thousands of yuan per box. Especially for patients who take them for a long time, the financial burden cannot be underestimated. Although the quality of original drugs is guaranteed, the high price has become the biggest obstacle faced by many patients.

In comparison, the launch of generic drugs in Laos provides a more cost-effective option for many patients. Currently, the generic version of sotoraxib produced by two pharmaceutical factories, Lucius in Laos and Bear in Bear, is already in circulation on the market. The price of a box of 120mg*56 tablets has dropped significantly to more than 1,000 yuan. This significant reduction in price significantly reduces the financial burden, allowing more patients with KRAS G12C mutations to continue to receive targeted therapies.

Although there is a big price difference between original drugs and generic drugs, they are basically the same in terms of drug ingredients and target mechanism of action. Some generic drug manufacturers in Laos already have relatively mature production technology and quality control standards. Patients who use generic drugs under the guidance of doctors are expected to obtain better therapeutic effects. For patients who are in urgent need of medication but have limited financial conditions, choosing the Laos generic version of sotorasibu is undoubtedly an option worth considering.

Reference materials:https://www.lumakras.com/